Wellington Management Group LLP Biomea Fusion, Inc. Transaction History

Wellington Management Group LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$4.14 - $15.3 $65,946 - $243,713	15,929 Added 15.54%	118,463 $533,000
Q1 2024 May 15, 2024	BUY	$13.92 - $19.5 $1.43 Million - $2 Million	102,534 New	102,534 $1.53 Million
Q4 2023 Feb 12, 2024	BUY	$8.37 - $19.8 $715,936 - $1.69 Million	85,536 New	85,536 $1.24 Million
Q4 2022 Feb 13, 2023	BUY	$6.3 - $11.6 $149,146 - $274,618	23,674 Added 36.67%	88,238 $743,000
Q3 2022 Nov 14, 2022	BUY	$9.51 - $13.61 $614,003 - $878,716	64,564 New	64,564 $631,000
Q1 2022 May 16, 2022	SELL	$4.39 - $9.03 $956,313 - $1.97 Million	-217,839 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$7.22 - $12.72 $3.87 Million - $6.82 Million	-536,079 Reduced 71.11%	217,839 $1.62 Million
Q3 2021 Nov 15, 2021	BUY	$10.0 - $15.99 $7.33 Million - $11.7 Million	732,559 Added 3429.74%	753,918 $9.02 Million
Q2 2021 Aug 16, 2021	BUY	$13.65 - $20.93 $291,550 - $447,043	21,359 New	21,359 $334,000

105

17.9M

1.68M

410K

Ticker BMEA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,290,600
Market Cap $119M
Description
Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.